Evidence map›Paper›PMID 36831477›Full record

ArticleCancers2023

Correlations between [

Ragnar Bruvoll, Johan Blakkisrud, Lars Tore Mikalsen, James Connelly, Caroline Stokke

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. [EJNMMI physics · 2026
    Article
  2. CanJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  3. [EJNMMI radiopharmacy and chemistry · 2024
    Article
  4. Models using comprehensive, lesion-level, longitudinal [European journal of nuclear medicine and molecular imaging · 2024
    Article
  5. Prediction of [EJNMMI physics · 2024
    Article
  6. Review
  7. The predictive value of pretherapy [European journal of nuclear medicine and molecular imaging · 2023
    Article
  8. Recent Advances inInternational journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ragnar BruvollDivision of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway.
Johan BlakkisrudDivision of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway.
Lars Tore MikalsenDivision of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway.
James ConnellyDivision of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway.ORCID 0000-0001-8444-5944
Caroline StokkeDivision of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway.ORCID 0000-0003-4465-9635

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this paper was to investigate correlations between pre- therapeutic [

methodsThis retrospective study included 301 tumours from 54 GEP-NET patients. The tumours were segmented on pre-therapeutic [

resultsMean SUV

conclusionsThere was a high inter- and intra-patient variability in tumour measurements, both for [

Indexed as

[177Lu]Lu-DOTA-TATE[68Ga]Ga-DOTA-TOCdosimetrypeptide receptor radionuclide therapyPET/CTprediction modelSPECT/CT

Identifiers

PMID36831477
PMCPMC9954147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.